ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2003

Conditions
Prostate Cancer
Interventions
DRUG

ABX-EGF

Trial Locations (9)

15232

University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh

19111

Fox Chase Cancer Center, Philadelphia

34652

Advanced Research Institute, New Port Richey

35294

University of Alabama at Birmingham, Birmingham

78229

Urology San Antonio Research, San Antonio

90095

UCLA School of Medicine, Los Angeles

94303

Stanford Medical Center, Stanford

98109

University of Washington, Seattle

98431

Madigan Army Medical Center, Tacoma

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

lead

Abgenix

INDUSTRY

NCT00061126 - ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body | Biotech Hunter | Biotech Hunter